Apyx Medical (NASDAQ:APYX) Announces Quarterly Earnings Results

Apyx Medical (NASDAQ:APYX) issued its quarterly earnings data on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.02, Zacks reports. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Price Performance

Shares of NASDAQ APYX traded up $0.02 during midday trading on Thursday, reaching $1.09. The company’s stock had a trading volume of 11,116 shares, compared to its average volume of 66,209. Apyx Medical has a one year low of $0.97 and a one year high of $1.99. The company has a market cap of $41.03 million, a price-to-earnings ratio of -1.31 and a beta of 1.18. The company has a 50 day moving average price of $1.43 and a 200 day moving average price of $1.38. The company has a current ratio of 5.46, a quick ratio of 4.52 and a debt-to-equity ratio of 3.03.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.